Treatment of emotional and cognitive disorders in patients with chronic cerebral ischemia
OBJECTIVE: To study clinical efficacy of the drug divasa in patients with chronic cerebral ischemia. MATERIAL AND METHODS: One hundred and forty-two patients, mean age 58,6±8,8 years, were treated during 11,9±0,2 weeks. Neurological examination and evaluation of a patient's status with psychometric scales were performed. RESULTS: The drug reduced anxiety, depressive and asthenic disorders beginning from the 4th week of treatment. The positive effect of treatment on cognitive functions appeared later. CONCLUSION: Divasa proved to be an effective drug in the complex treatment of patients with chronic disturbances of cerebral blood circulation.